MedPath

Early Life Exposures Among Children With Sickle Cell Disease

Not Applicable
Not yet recruiting
Conditions
Sickle Cell Disease
Adverse Childhood Experiences
Breastfeeding
Interventions
Behavioral: Breastfeeding support group
Other: Observation
Registration Number
NCT05377372
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This study is being conducted to determine the relationship between early childhood exposures, such as Adverse Childhood Experiences, Social Determinants of Health and nutrition/breastfeeding, among children with sickle cell disease, and behavioral interventions aimed to reshape psychological resilience and lifestyle factors towards positive health outcomes.

Detailed Description

During year 3 of the award period, 20 mother-infant dyads will be randomly assigned to either a community-based breastfeeding support group or observation. Acceptability to enrollment, intervention adherence for at least 6 months and preliminary effectiveness will be captured. Biomarkers of inflammation, development of asthma and incidences of pain and/or acute chest syndrome will be compared among the intervention and control groups.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • mother of infant with sickle cell disease
  • resides within the city of Birmingham, Alabama or in close proximity
Exclusion Criteria
  • prescribed teratogenic medications
  • no/limited internet access

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Breastfeeding Intervention GroupBreastfeeding support groupTen mother-infant dyads will be recruited to a six-month, community-based intervention aimed to promote sustained breastfeeding for at least six months among mothers of infants with sickle cell disease. The intervention will include an online, social media-based support group, online educational modules, monthly in-person educational sessions, access to free breast pump rentals, and monthly peer-led home visits by certified Vanderbilt-affiliated Maternal Infant Health Outreach Specialists. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.
Observation GroupObservationA 24 month observation of 10 mother-infant dyads affected by sickle cell disease that initiate breastfeeding. These dyads will observed for breastfeeding exclusivity/dosage and duration. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.
Primary Outcome Measures
NameTimeMethod
Acceptance and Retention of Mothers of Infants with Sickle Cell Disease to a Community-based Breastfeeding Intervention6 months

acceptance (number of mothers enrolled/number of mothers approached) and retention (number of mothers to complete 6 month support group intervention/number enrolled)

Preliminary Effectiveness2 years

Percentage of mothers of infants with sickle cell disease that successful complete 6 months of breastfeeding, comparing the intervention vs. control groups

Secondary Outcome Measures
NameTimeMethod
Asthma4 year follow up period

Prevalence of asthma among children with sickle cell disease that were breastfed compared to those that were not

Acute chest syndrome4 year follow up period

Incidence rate of episodes of acute chest syndrome among children with sickle cell disease that were vs. were not breastfed

Trial Locations

Locations (1)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath